Assignee
TRIS PHARMA INC
US·47 granted patents·22 pending applications·1,549 citations·filing 2012–2025
Top patents by PatentIndex Score
69 records- 0199US10933143B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2019·Granted Mar 2, 2021·36 cites·22 claims
- 0299US10668163B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2019·Granted Jun 2, 2020·36 cites·27 claims
- 0399US10172958B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2016·Granted Jan 8, 2019·37 cites·23 claims
- 0499US10086087B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2017·Granted Oct 2, 2018·36 cites·22 claims
- 0599US9675703B2Modified release formulations containing drug - ion exchange resin complexesTRIS PHARMA INC·Filed 2016·Granted Jun 13, 2017·49 cites·21 claims
- 0699US9675704B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2016·Granted Jun 13, 2017·49 cites·20 claims
- 0799US9549989B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2016·Granted Jan 24, 2017·40 cites·14 claims
- 0899US9522191B2Modified release formulations containing drug—ion exchange resin complexesTRIS PHARMA INC·Filed 2014·Granted Dec 20, 2016·40 cites·19 claims
- 0999US9198864B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2015·Granted Dec 1, 2015·55 cites·14 claims
- 1099US8883217B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2014·Granted Nov 11, 2014·57 cites·18 claims
- 1199US8790700B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2013·Granted Jul 29, 2014·70 cites·29 claims
- 1299US8747902B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2013·Granted Jun 10, 2014·70 cites·30 claims
- 1399US8597684B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2013·Granted Dec 3, 2013·77 cites·29 claims
- 1499US8491935B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2012·Granted Jul 23, 2013·95 cites·24 claims
- 1598US10857143B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2019·Granted Dec 8, 2020·45 cites·27 claims
- 1698US10507203B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2018·Granted Dec 17, 2019·42 cites·19 claims
- 1798US9844545B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2017·Granted Dec 19, 2017·43 cites·30 claims
- 1898US9844544B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2016·Granted Dec 19, 2017·46 cites·40 claims
- 1998US9545399B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2016·Granted Jan 17, 2017·50 cites·27 claims
- 2098US9295642B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2015·Granted Mar 29, 2016·61 cites·29 claims
- 2198US9180100B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2015·Granted Nov 10, 2015·55 cites·30 claims
- 2298US9040083B2Orally effective methylphenidate extended release powder and aqueous suspension productTRIS PHARMA INC·Filed 2014·Granted May 26, 2015·51 cites·22 claims
- 2398US8999386B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2014·Granted Apr 7, 2015·56 cites·30 claims
- 2498US8956649B2Orally effective methylphenidate extended release powder and aqueous suspension productTRIS PHARMA INC·Filed 2014·Granted Feb 17, 2015·51 cites·43 claims
- 2598US8778390B2Orally effective methylphenidate extended release powder and aqueous suspension productTRIS PHARMA INC·Filed 2013·Granted Jul 15, 2014·62 cites·30 claims
- 2698US8563033B1Orally effective methylphenidate extended release powder and aqueous suspension productTRIS PHARMA INC·Filed 2013·Granted Oct 22, 2013·67 cites·19 claims
- 2797US11103494B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2020·Granted Aug 31, 2021·5 cites·30 claims
- 2897US11103495B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2021·Granted Aug 31, 2021·5 cites·30 claims
- 2996US9867797B2Benzonatate modified release solid tablets and capsulesTRIS PHARMA INC·Filed 2016·Granted Jan 16, 2018·38 cites·41 claims
- 3096US9408823B2Benzonatate modified release solid tablets and capsulesTRIS PHARMA INC·Filed 2015·Granted Aug 9, 2016·44 cites·21 claims
- 3196US9180104B2Benzonatate modified release solid tablets and capsulesTRIS PHARMA INC·Filed 2014·Granted Nov 10, 2015·59 cites·30 claims
- 3288US11241411B2Benzonatate modified release solid tablets and capsulesTRIS PHARMA INC·Filed 2019·Granted Feb 8, 2022·3 cites·20 claims
- 3387US11337920B2Pharmaceutical composition comprising GHB gastro-retentive raft forming systems having trigger pulse drug releaseTRIS PHARMA INC·Filed 2018·Granted May 24, 2022·7 cites·16 claims
- 3487US2023233542A1Methylphenidate Extended Release Chewable TabletTRIS PHARMA INC·Filed 2023·Application pending·0 cites
- 3585US11666546B2GHB pharmaceutical compositions comprising a floating interpenetrating polymer network forming systemTRIS PHARMA INC·Filed 2018·Granted Jun 6, 2023·5 cites·19 claims
- 3684US11337919B2Modified release drug powder composition comprising gastro-retentive RAFT forming systems having trigger pulse drug releaseTRIS PHARMA INC·Filed 2018·Granted May 24, 2022·5 cites·18 claims
- 3784US2022168432A1Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2022·Application pending·0 cites
- 3883US11590081B1Extended release amphetamine tabletsTRIS PHARMA INC·Filed 2018·Granted Feb 28, 2023·1 cites·37 claims
- 3983US11590228B1Extended release amphetamine compositionsTRIS PHARMA INC·Filed 2019·Granted Feb 28, 2023·1 cites·18 claims
- 4081US2025064747A1Extended release amphetamine tabletsTRIS PHARMA INC·Filed 2024·Application pending·0 cites
- 4180US12076441B2Extended release amphetamine tabletsTRIS PHARMA INC·Filed 2023·Granted Sep 3, 2024·0 cites·6 claims
- 4280US2023165837A1Novel clonidine formulationTRIS PHARMA INC·Filed 2022·Application pending·0 cites
- 4379US2019151460A1Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2019·Application pending·0 cites
- 4479US2021162055A1Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2021·Application pending·0 cites
- 4577US11633389B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2020·Granted Apr 25, 2023·0 cites·30 claims
- 4677US2021038734A1Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2020·Application pending·0 cites
- 4775US2025099376A1Pharmaceutical composition comprising ghb gastro-retentive raft forming systems having trigger pulse drug releaseTRIS PHARMA INC·Filed 2024·Application pending·0 cites
- 4875US2018000954A1Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2017·Application pending·0 cites
- 4972US2017319566A1Methylphenidate Extended Release Chewable TabletTRIS PHARMA INC·Filed 2017·Application pending·0 cites
- 5072US2023233683A1Extended release amphetamine compositionsTRIS PHARMA INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when TRIS PHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →